1.
BEKADJA MA. OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY. Mediterr J Hematol Infect Dis [Internet]. 2017 Oct. 25 [cited 2021 Jun. 14];9(1):e2017062. Available from: https://www.mjhid.org/index.php/mjhid/article/view/2017.062